Search result for Immunomedics
GILEAD SCIENCES TO TAKE OVER IMMUNOMEDICS FOR $21 BILLION
Highlights
• The company would issue a tender offer to purchase all the outstanding shares of Immunomedics for $88 per share that represent a premium of nearly 108% over their last closing price of $42.25 on Friday said Gilead
• Daniel O'Day, Chief Executive Offi...